🟢 Nasus Pharma is trading 7.15% up today amid broader risk-on market sentiment

Nasus Pharma is trading 7.15% higher at $3.47, amid a broader risk-on session.

• The S&P 500 and Nasdaq Composite are both rising more than 0.5%.
• No clear company-specific announcement, filing, analyst action, or other direct catalyst was identified for August 13, 2026.
• Recent indexed coverage mainly references earlier CEO and investor-event news; the move appears primarily aligned with positive macro market sentiment.